Janssen Pharmaceuticals

Janssen Pharmaceuticals (formerly Centocor) is a pharmaceutical company that conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer.

Employee Rating

Parent CompanyJohnson & Johnson
HQRaritan, NJ, US
Cybersecurity ratingBMore
Janssen Pharmaceuticals was founded in 1953 and is headquartered in Raritan, NJ, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Janssen Pharmaceuticals

Joaquin Duato

Joaquin Duato

Vice Chairman of the Executive Committee Johnson & Johnson
Paul Stoffels

Paul Stoffels

Vice Chairman of the Executive Committee Chief Scientific Officer Johnson & Johnson
Scott White

Scott White

Company Group Chairman North America Pharmaceuticals Johnson & Johnson
Show more

Janssen Pharmaceuticals Office Locations

Janssen Pharmaceuticals has offices in Raritan, Wien, Birkerød, Espoo and in 4 other locations
Raritan, NJ, US (HQ)
1000 US-202
Wien, AT
Biz Zwei, Vorgartenstraße 206B
Birkerød, DK
Bistrupvej 133
Espoo, FI
Vaisalantie 2
Oslo, NO
Drammensveien 288
Beograd, RS
Omladinskih brigada 88b, Beograd
Show all (9)

Janssen Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date



Janssen Pharmaceuticals is a subsidiary of Johnson & Johnson

Janssen Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Janssen Pharmaceuticals Online and Social Media Presence

Embed Graph

Janssen Pharmaceuticals Company Culture

  • Overall Culture



  • CEO Rating



  • Compensation



Learn more on Comparably

Janssen Pharmaceuticals News and Updates

Global Immunotherapy Drugs Market Outlook & Forecast 2021-2026 Featuring F. Hoffmann-La Roche, Bristol Myers Squibb Co, Merck & Co., GSK, Novartis, AstraZeneca, and Janssen Pharmaceuticals

Dublin, Oct. 28, 2021 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market - Global Outlook & Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.The global immunotherapy drugs market was valued at USD 169.47 billion in 2020 and is expected to reach USD 326.36 billion…

Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

TORONTO, July 24, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced that Janssen Pharmaceuticals, Inc. (“Janssen”), has approved its wholly owned subsidiary, Canabo Medical Inc. (“Canabo”) as an administrator and prescriber of an…

CNS Therapeutics Market 2018 Global Analysis By Key Players – Pfizer, Janssen Pharmaceuticals, Allergan, Lundbeck, Teva

WiseGuyReports.Com Publish a New Market Research Report On –“ CNS Therapeutics 2018 Global Market Outlook,Research,Trends and Forecast to 2023”. Posted via Industry Today. Follow us on Twitter @IndustryToday

Janssen Pharmaceuticals Frequently Asked Questions

  • When was Janssen Pharmaceuticals founded?

    Janssen Pharmaceuticals was founded in 1953.

  • Who are Janssen Pharmaceuticals key executives?

    Janssen Pharmaceuticals's key executives are Joaquin Duato, Paul Stoffels and Scott White.

  • How many employees does Janssen Pharmaceuticals have?

    Janssen Pharmaceuticals has 27,329 employees.

  • Who are Janssen Pharmaceuticals competitors?

    Competitors of Janssen Pharmaceuticals include Amgen, MD Anderson Cancer Center and C4 Therapeutics.

  • Where is Janssen Pharmaceuticals headquarters?

    Janssen Pharmaceuticals headquarters is located at 1000 US-202, Raritan.

  • Where are Janssen Pharmaceuticals offices?

    Janssen Pharmaceuticals has offices in Raritan, Wien, Birkerød, Espoo and in 4 other locations.

  • How many offices does Janssen Pharmaceuticals have?

    Janssen Pharmaceuticals has 9 offices.